Ono Pharmaceutical Co. Ltd. (ON4) - Financials, income statement (quarterly)

9.25 EUR

0.25

2.78%

Last update May 16, 7:31 PM CEST

Market closed

Day range

9.25

9.10000

9.25

Previous close

Open

9.10000

Access this stock data via API

Ono Pharmaceutical Co. Ltd.

9.25

0.25

2.78%

Fiscal date	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total reported revenue	112.8B	131.2B	138.7B	120.0B
Cost of revenue	31.7B	30.7B	34.6B	30.2B
Gross profit	81.1B	100.5B	104.1B	89.8B
Operating expense
Research & development	35.7B	27.1B	24.8B	24.6B
Selling general and admin	27.0B	25.7B	24.1B	23.5B
Other operating expenses	3.3B	165M	289M	553M
Operating income	15.3B	47.6B	55.7B	41.3B
Non operating interest income
Income	907M	1.5B	1.2B	1.3B
Expense	-229M	1.1B	20M	241M
Other income expense	—	—	—	—
Pretax income	16.4B	48.0B	56.9B	42.4B
Tax provision	-988M	11.9B	14.2B	10.6B
Net income	17.4B	36.1B	42.7B	31.8B
Basic EPS	—	75.8	88.2	65.2
Diluted EPS	—	75.8	88.2	65.2
Basic average shares	—	77.4B	78.7B	79.2B
Diluted average shares	—	77.4B	78.7B	79.2B
EBITDA	20.9B	53.4B	61.5B	47.1B
Net income from continuing op.	16.4B	48.0B	56.9B	42.4B
Minority interests	4M	-37M	-29M	0
Preferred stock dividends	0	0	0	0